Literature DB >> 26365799

Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.

Christopher Bryan1, Cory Rice2, Hunter Hoffman3, Michael Harkisheimer3, Melanie Sweeney1, Emmanuel Skordalakes4.   

Abstract

BIBR1532 is a highly specific telomerase inhibitor, although the molecular basis for inhibition is unknown. Here we present the crystal structure of BIBR1532 bound to Tribolium castaneum catalytic subunit of telomerase (tcTERT). BIBR1532 binds to a conserved hydrophobic pocket (FVYL motif) on the outer surface of the thumb domain. The FVYL motif is near TRBD residues that bind the activation domain (CR4/5) of hTER. RNA binding assays show that the human TERT (hTERT) thumb domain binds the P6.1 stem loop of CR4/5 in vitro. hTERT mutations of the FVYL pocket alter wild-type CR4/5 binding and cause telomere attrition in cells. Furthermore, the hTERT FVYL mutations V1025F, N1028H, and V1090M are implicated in dyskeratosis congenita and aplastic anemia, further supporting the biological and clinical relevance of this novel motif. We propose that CR4/5 contacts with the telomerase thumb domain contribute to telomerase ribonucleoprotein assembly and promote enzymatic activity.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26365799      PMCID: PMC4598299          DOI: 10.1016/j.str.2015.08.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  37 in total

Review 1.  G-quadruplexes as targets for drug design.

Authors:  L H Hurley; R T Wheelhouse; D Sun; S M Kerwin; M Salazar; O Y Fedoroff; F X Han; H Han; E Izbicka; D D Von Hoff
Journal:  Pharmacol Ther       Date:  2000-03       Impact factor: 12.310

2.  Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts.

Authors:  Y E Yegorov; D N Chernov; S S Akimov; N L Bolsheva; A A Krayevsky; A V Zelenin
Journal:  FEBS Lett       Date:  1996-07-01       Impact factor: 4.124

3.  Human telomerase model shows the role of the TEN domain in advancing the double helix for the next polymerization step.

Authors:  Kamil Steczkiewicz; Michael T Zimmermann; Mateusz Kurcinski; Benjamin A Lewis; Drena Dobbs; Andrzej Kloczkowski; Robert L Jernigan; Andrzej Kolinski; Krzysztof Ginalski
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

4.  RNA-protein binding interface in the telomerase ribonucleoprotein.

Authors:  Christopher J Bley; Xiaodong Qi; Dustin P Rand; Chad R Borges; Randall W Nelson; Julian J-L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

5.  Structural basis for protein-RNA recognition in telomerase.

Authors:  Jing Huang; Andrew F Brown; Jian Wu; Jing Xue; Christopher J Bley; Dustin P Rand; Lijie Wu; Rongguang Zhang; Julian J-L Chen; Ming Lei
Journal:  Nat Struct Mol Biol       Date:  2014-05-04       Impact factor: 15.369

Review 6.  Telomerase: a target for cancer therapeutics.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

7.  Structure of the Tribolium castaneum telomerase catalytic subunit TERT.

Authors:  Andrew J Gillis; Anthony P Schuller; Emmanuel Skordalakes
Journal:  Nature       Date:  2008-08-31       Impact factor: 49.962

Review 8.  Telomerase and cancer therapeutics.

Authors:  Calvin B Harley
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

9.  3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.

Authors:  Xiaohong Liu; Hazuki Takahashi; Yoko Harada; Tsukasa Ogawara; Yuta Ogimura; Yoshiyuku Mizushina; Mineo Saneyoshi; Toyofumi Yamaguchi
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971

10.  Structure of active dimeric human telomerase.

Authors:  Anselm Sauerwald; Sara Sandin; Gaël Cristofari; Sjors H W Scheres; Joachim Lingner; Daniela Rhodes
Journal:  Nat Struct Mol Biol       Date:  2013-03-10       Impact factor: 15.369

View more
  32 in total

1.  Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.

Authors:  Hunter Hoffman; Cory Rice; Emmanuel Skordalakes
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

Review 2.  Structural biology of telomerase and its interaction at telomeres.

Authors:  Yaqiang Wang; Juli Feigon
Journal:  Curr Opin Struct Biol       Date:  2017-07-18       Impact factor: 6.809

Review 3.  In perspective: An update on telomere targeting in cancer.

Authors:  Eric T Sugarman; Gao Zhang; Jerry W Shay
Journal:  Mol Carcinog       Date:  2019-05-06       Impact factor: 4.784

4.  PGC1α Regulates the Endothelial Response to Fluid Shear Stress via Telomerase Reverse Transcriptase Control of Heme Oxygenase-1.

Authors:  Shashi Kant; Khanh-Van Tran; Miroslava Kvandova; Amada D Caliz; Hyung-Jin Yoo; Heather Learnard; Ana C Dolan; Siobhan M Craige; Joshua D Hall; Juan M Jiménez; Cynthia St Hilaire; Eberhard Schulz; Swenja Kröller-Schön; John F Keaney
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-11-18       Impact factor: 8.311

Review 5.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

6.  Structure of active human telomerase with telomere shelterin protein TPP1.

Authors:  Baocheng Liu; Yao He; Yaqiang Wang; He Song; Z Hong Zhou; Juli Feigon
Journal:  Nature       Date:  2022-04-13       Impact factor: 69.504

7.  Structural Roles of Noncoding RNAs in the Heart of Enzymatic Complexes.

Authors:  William J Martin; Nicholas J Reiter
Journal:  Biochemistry       Date:  2016-12-29       Impact factor: 3.162

Review 8.  Structural biology of telomeres and telomerase.

Authors:  Eric M Smith; Devon F Pendlebury; Jayakrishnan Nandakumar
Journal:  Cell Mol Life Sci       Date:  2019-11-14       Impact factor: 9.207

Review 9.  Telomerase as a therapeutic target in glioblastoma.

Authors:  Elisa Aquilanti; Lauren Kageler; Patrick Y Wen; Matthew Meyerson
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 13.029

10.  How DNA damage and non-canonical nucleotides alter the telomerase catalytic cycle.

Authors:  Samantha L Sanford; Griffin A Welfer; Bret D Freudenthal; Patricia L Opresko
Journal:  DNA Repair (Amst)       Date:  2021-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.